Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia.

Authors	Alessandro Cellini, Federico Scarmozzino, Alberto Friziero, Valentina Trimarco, Angelo Paolo Dei Tos, Livio Trentin, Marco Pizzi, Andrea Visentin
Journal	Annals of hematology (Ann Hematol) Vol. 102 Issue 3 Pg. 681-682 (03 2023) ISSN: 1432-0584 [Electronic] Germany
PMID	36542103 (Publication Type: Letter)
Chemical References	venetoclax Rituximab Bridged Bicyclo Compounds, Heterocyclic
Topics	Humans Leukemia, Lymphocytic, Chronic, B-Cell (drug therapy) Neoplasm, Residual Splenomegaly Rituximab (therapeutic use) Bridged Bicyclo Compounds, Heterocyclic (therapeutic use) Antineoplastic Combined Chemotherapy Protocols

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!